Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 5 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Vaxcyte INC paid sponsored hires in similar roles4 certified filings for “Scientist II, Conjugation Development” (Biochemists and Biophysicists) in CA: $152k–$190k, median $164k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 5 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Vaxcyte INC paid sponsored hires in similar roles
- 4 certified filings for “Scientist II, Conjugation Development” (Biochemists and Biophysicists) in CA: $152k–$190k, median $164k. Most were filed at wage level IV (50%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Join our Mission to Protect Humankind!
Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance.
WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values:
*RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.
*AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.
*LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.
*MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.
Summary:
Vaxcyte is seeking an accomplished Staff Scientist, Immunoassay Developmentto join the CMC Immunoassay group. This role will provide scientific and strategic leadership for the development, qualification, characterization, governance, and lifecycle management of critical reagents and reference materials that support immunoassays across Vaxcyte's vaccine pipeline.
The Staff Scientist will serve as a hands-on technical expert responsible for strengthening Vaxcyte’s immunoassay capability across the vaccine pipeline. This includes developing new fit-for-purpose immunoassays, evaluating innovative immunoassay platforms, advancing assay robustness, supporting method transfer and validation readiness, contributing to immunoassay control strategy, and providing senior-level scientific guidance to cross-functional teams.
This is not a primary people-management role. The Staff Scientist may mentor junior scientists and influence technical direction across programs, but the primary accountability is scientific depth, independent technical contribution, experimental strategy, complex data interpretation, and advancement of immunoassay capability.
Essential Functions:
• Serve as a senior technical expert and individual contributor for immunoassay development across Vaxcyte’s vaccine pipeline.
• Lead and directly execute complex laboratory studies supporting immunoassay development, optimization, platform evaluation, qualification readiness, validation readiness, method transfer support, lifecycle management, and routine analytical testing.
• Develop new fit-for-purpose immunoassays supporting potency, antigenicity, identity, impurity, characterization, comparability, release, stability, and lifecycle needs.
• Provide scientific leadership for assay design, including assay format selection, sample preparation strategy, reagent strategy, plate or bead format selection, signal detection approach, system suitability, data analysis model, robustness assessment, and control strategy considerations.
• Evaluate innovative and alternative immunoassay platforms and formats, including ELISA, MSD, multiplex assays, bead-based assays, automation-enabled workflows, and other ligand-binding technologies.
• Design and execute studies to compare assay platforms and translate experimental findings into scientific recommendations for method selection, optimization, and long-term control strategy.
• Independently troubleshoot immunoassay performance trends using structured, data-driven experimen
Apply on company site ↗